Published in Arthritis Rheum on July 01, 2007
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.26
Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. Arthritis Res Ther (2009) 1.26
Stem cell transplantation for rheumatic autoimmune diseases. Arthritis Res Ther (2008) 0.93
Thymic function in juvenile idiopathic arthritis. Ann Rheum Dis (2008) 0.85
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results. Bone Marrow Transplant (2011) 0.85
Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines. J Clin Immunol (2007) 0.83
Haematopoietic stem cell transplantation for autoimmune diseases. Nat Rev Rheumatol (2017) 0.81
Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation. Immunology (2014) 0.78
Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow. PLoS One (2014) 0.78
[Current value of stem-cell transplantation in autoimmune diseases]. Z Rheumatol (2008) 0.76
Undifferentiated spondyloarthritis following allogeneic stem cell transplantation. BMC Musculoskelet Disord (2010) 0.75
Stem cell therapy: resetting autoimmunity or postponing the inevitable? Ther Adv Musculoskelet Dis (2011) 0.75
Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Ther (2017) 0.75
Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartment. Arthritis Rheumatol (2014) 0.75
New frontiers in the treatment of systemic juvenile idiopathic arthritis. F1000Res (2017) 0.75
[Remission in pediatric rheumatology]. Z Rheumatol (2013) 0.75
Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr (1997) 3.63
Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet (1999) 3.35
Comparison of behavior modification with and without swaddling as interventions for excessive crying. J Pediatr (2006) 2.67
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med (1989) 2.42
Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet (1999) 2.39
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child (2004) 2.26
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Bullous lesions in Henoch Schönlein Purpura as indication to start systemic prednisone. Acta Paediatr (2009) 2.07
[Reflex sympathetic dystrophy also in children]. Ned Tijdschr Geneeskd (1994) 2.04
Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum (2000) 1.95
Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy (2009) 1.84
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a Web-based survey. Arthritis Care Res (Hoboken) (2012) 1.73
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis (2008) 1.63
Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer (1992) 1.59
Physical activity and health related physical fitness in children with juvenile idiopathic arthritis. Ann Rheum Dis (2003) 1.58
Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum (2006) 1.51
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51
Biotyping of Enterobacteriaceae as a test for the evaluation of isolation systems. J Hyg (Lond) (1972) 1.50
Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology (Oxford) (2005) 1.48
Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections. J Infect Dis (1977) 1.48
Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet (1991) 1.45
Prediction of severe disseminated adenovirus infection by serum PCR. Lancet (2001) 1.44
European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet (1990) 1.44
Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr (1994) 1.42
Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients. Bone Marrow Transplant (2005) 1.41
Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol (2009) 1.41
[Three children with general malaise, fever, weight loss and cervical lymphadenopathy]. Ned Tijdschr Geneeskd (2004) 1.40
Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J Pediatr (1994) 1.40
[3 adolescents with hip pain caused by idiopathic chondrolysis]. Ned Tijdschr Geneeskd (1993) 1.39
Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol Cell Biol (2000) 1.38
Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37
The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol (2001) 1.35
Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant (2003) 1.34
Reconventionalization following antibiotic decontamination in man and animals. Am J Clin Nutr (1977) 1.33
Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene. Nucleic Acids Res (1987) 1.31
Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol (1993) 1.31
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis (2011) 1.29
The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet (2001) 1.29
Primary immunodeficiency disorders in Sweden: cases among children, 1974-1979. J Clin Immunol (1982) 1.28
T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies. J Immunol (1981) 1.26
Chromatin mobility is increased at sites of DNA double-strand breaks. J Cell Sci (2012) 1.24
Membrane-associated immunoglobulin determinants on bone marrow and blood lymphocytes in the pediatric age group and on fetal tissues. Ann N Y Acad Sci (1975) 1.24
Musculoskeletal manifestations of lysosomal storage disorders. Ann Rheum Dis (2009) 1.22
HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins. J Infect Dis (1986) 1.20
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet (2007) 1.20
Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family. Pediatrics (1983) 1.16
Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol (2001) 1.14
Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Pathol (1990) 1.14
Incidence and hemodynamic characteristics of near-fainting in healthy 6- to 16-year old subjects. J Am Coll Cardiol (1995) 1.13
Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis (2004) 1.12
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11
The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis. Ann Rheum Dis (2008) 1.11
Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res (1993) 1.11
Whole-blood lymphocyte cultures. J Immunol Methods (1989) 1.11
Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr (1995) 1.10
Development of a Costa Rican version of the Childhood Health Assessment Questionnaire. J Rheumatol (1997) 1.10
Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A (1997) 1.10
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia (1997) 1.10
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum (2003) 1.09
PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it. Ann Rheum Dis (2005) 1.09
Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Hum Genet (2001) 1.08
Autoantibodies to Tamm-Horsfall protein, a tool for diagnosing the level of urinary-tract infection. Lancet (1976) 1.07
Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study. Pediatrics (1992) 1.07
Comparison of internal diameter of great arteries in congenital heart disease. A cross-sectional echocardiographic study. Br Heart J (1983) 1.06
Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study. Clin Exp Immunol (1976) 1.06
Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. Arthritis Rheum (2009) 1.06
Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum (1998) 1.05
Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study. Clin Exp Rheumatol (2007) 1.04
Craniofacial structure in children with juvenile chronic arthritis (JCA) compared with healthy children with ideal or postnormal occlusion. Am J Orthod Dentofacial Orthop (1995) 1.04
Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin Infect Dis (2002) 1.04
Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest (1995) 1.04
Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant (2005) 1.04
The natural history of juvenile chronic arthritis: a population based cohort study. I. Onset and disease process. J Rheumatol (1995) 1.02
Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for alpha(1)-adrenergic receptors. J Neuroimmunol (2000) 1.02
Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum (1996) 1.01
Restricted utilization of germ-line VH3 genes and short diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements. Eur J Immunol (1992) 1.01
The pain threshold in juvenile chronic arthritis. Br J Rheumatol (1995) 1.01
CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today (1996) 1.00
Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) (2003) 1.00
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation. Leukemia (2010) 1.00